Digitoxin Lowers HF Events in Symptomatic Patients

Study results show mortality benefit from low-dose digitoxin for heart failure in symptomatic patients with reduced ejection fraction.
Medscape Medical News

source https://www.medscape.com/viewarticle/new-data-support-digitoxin-comeback-some-heart-failure-2025a1000myi?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension